Search clinical trials for: SARS-CoV-2 vaccine

Total 56562 results

Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

COVID-19
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Agencia Mexicana de Cooperación...

Completed

Study of a Live rNDV Based Vaccine Against COVID-19

SARS-CoV-2 Infection

Mexico
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

COVID-19

Brazil, Malaysia
Stemirna Therapeutics

Recruiting

New Generation mRNA Booster Vaccine Against Emerging VOCs

Efficacy | Safety | Immunogenicity

Lao People's Democratic Republic
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity (COVID-19)

COVID-19 Pandemic

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization (COVID-19)

COVID-19 Pandemic

China
Heinrich-Heine University, Duesseldorf
The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit...

Completed

Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals (RES-Q-HR)

Corona Virus Infection | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 PCR Test Positive

Germany
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; Right to Care and other collaborators

Recruiting

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (Sisonke Boost)

SARS CoV 2 Infection

South Africa
Pontificia Universidad Catolica de Chile

Recruiting

Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

Sars-CoV-2 Infection

Chile
BioNTech SE
Pfizer

Completed

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

SARS-CoV-2 Infection, COVID19

United States, Brazil, Germany, Mexico
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

COVID-19 and Venous Thromboembolism Risk

Covid19 | Venous Thromboembolism

United States
Assistance Publique - Hôpitaux de Paris
PRODISS; WEEZEVENT

Completed

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event (SPRING)

Covid19

France
Huashan Hospital

Recruiting

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

COVID-19 | Vaccine Reaction

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
University of Milano Bicocca

Recruiting

The Natural History of Hospitalized COVID-19 Patients (STORM)

Sars-CoV2

Italy
Al-Azhar University
Ain Shams University; South Valley University; Helwan University; National Liver...

Completed

Non-invasive Predictors of ICU Admission and Mortality in Initially Asymptomatic COVID-19 Patients (COVID-HRCT)

COVID-19

Egypt
BioNTech SE

Completed

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

COVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)

United States, Germany, Turkey, South Africa
PT Bio Farma
Faculty of Medicine, Diponegoro University, Semarang; Faculty of Medicine,... and other collaborators

Completed

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19

Indonesia
Ankara City Hospital Bilkent
The Scientific and Technological Research Council of Turkey; MonitorCRO

Recruiting

Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine

COVID-19

Turkey
University of Patras

Completed

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

Vaccine Reaction | SARS-CoV2 Infection

Greece
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

COVID-19

China
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

COVID-19

China
AusDiagnostics Pty Ltd.

Not yet recruiting

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Respiratory Viral Infection
Alvea Holdings, LLC

Completed

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Sars-CoV-2 Infection

South Africa
First Affiliated Hospital Xi'an Jiaotong University

Completed

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (FASTER)

SARS CoV 2 Infection

China
Affiliated Hospital of Yunnan University
Kunming Medical University; Yunnan University

Completed

A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

COVID-19

China
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; University Hospital Tuebingen; Philipps... and other collaborators

Withdrawn

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

Covid19
University of Erlangen-Nürnberg Medical School

Recruiting

SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) (SARS-CoV2_KIDS)

SARS-Cov2

Germany
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak (COVEMUZ)

Sars-CoV2

Belgium
Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae (COV-RECUP)

Sars-CoV2

France
Institut National de la Santé Et de la Recherche...

Completed

Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis (SAPRIS-SERO)

SARS-CoV 2

France
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Active, not recruiting

Tocilizumab Treatment in Patients With COVID-19

Sars-CoV2

Mexico
Ology Bioservices
Enabling Biotechnologies (EB)

Completed

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

SARS-CoV-2

United States
Direction Centrale du Service de Santé des Armées

Completed

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling (CoviDiagMS)

SARS-CoV 2

France
IRCCS San Raffaele Roma

Completed

COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility (COVID-19)

SARS-Cov2

Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaborators

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

SARS-CoV 2

United States
Fondazione Epatocentro Ticino

Active, not recruiting

Methylene Blue Treatment of COVID-19

SARS-CoV2

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP (FamilyPEDCOVID)

SARS-CoV2

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy (TRANSCOVID)

Sars-CoV2

France
Direction Centrale du Service de Santé des Armées

Completed

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) (EpiCovCreil)

Sars-CoV2

France
Centre Hospitalier Universitaire Vaudois

Completed

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. (RESTART)

SARS-CoV-2

Switzerland
Direction Centrale du Service de Santé des Armées

Completed

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff (SEROSARSCOV)

Sars-CoV2

France
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Pfizer

Recruiting

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

United States, United Kingdom, Mexico, South Africa, Japan, Bulgaria, Hungary, Puerto Rico
Shaare Zedek Medical Center
Ministry of Health, Israel

Unknown

COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity

SARS-CoV-2 Infection

Israel
Toscana Life Sciences Sviluppo s.r.l.
Cross Research S.A.

Completed

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. (MAD0004J08)

COVID-19 Virus Disease

Italy
Livzon Pharmaceutical Group Inc.

Completed

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study (COVID-19)

COVID-19 Pandemic

Malaysia, Pakistan
Livzon Pharmaceutical Group Inc.

Active, not recruiting

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine (Omicron)

COVID-19 Pandemic

China
Assistance Publique - Hôpitaux de Paris

Completed

Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns (COVIPREG)

Pregnancy

France

Search clinical trials for: SARS-CoV-2 vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations